Chemicals - Specialty
Compare Stocks
2 / 10Stock Comparison
AVNT vs BCPC
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
AVNT vs BCPC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $3.35B | $5.11B |
| Revenue (TTM) | $3.28B | $1.06B |
| Net Income (TTM) | $158M | $158M |
| Gross Margin | 31.7% | 36.3% |
| Operating Margin | 9.3% | 21.0% |
| Forward P/E | 12.0x | 30.9x |
| Total Debt | $1.92B | $192M |
| Cash & Equiv. | $511M | $75M |
AVNT vs BCPC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| Balchem Corporation (BCPC) | 100 | 158.5 | +58.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AVNT vs BCPC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AVNT is the clearest fit if your priority is income & stability.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
- Lower P/E (12.0x vs 30.9x)
- 2.9% yield, 14-year raise streak, vs BCPC's 0.5%
BCPC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 160.5% 10Y total return vs AVNT's 27.8%
- Lower volatility, beta 0.33, Low D/E 15.3%, current ratio 2.07x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs AVNT's 0.6% | |
| Value | Lower P/E (12.0x vs 30.9x) | |
| Quality / Margins | 15.0% margin vs AVNT's 4.8% | |
| Stability / Safety | Beta 0.33 vs AVNT's 1.19, lower leverage | |
| Dividends | 2.9% yield, 14-year raise streak, vs BCPC's 0.5% | |
| Momentum (1Y) | +4.1% vs BCPC's -2.2% | |
| Efficiency (ROA) | 9.4% ROA vs AVNT's 2.6%, ROIC 12.2% vs 3.9% |
AVNT vs BCPC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AVNT vs BCPC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVNT is the larger business by revenue, generating $3.3B annually — 3.1x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to AVNT's 4.8%. On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.3B | $1.1B |
| EBITDAEarnings before interest/tax | $445M | $267M |
| Net IncomeAfter-tax profit | $158M | $158M |
| Free Cash FlowCash after capex | $205M | $182M |
| Gross MarginGross profit ÷ Revenue | +31.7% | +36.3% |
| Operating MarginEBIT ÷ Revenue | +9.3% | +21.0% |
| Net MarginNet income ÷ Revenue | +4.8% | +15.0% |
| FCF MarginFCF ÷ Revenue | +6.3% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | +8.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.8% | +10.6% |
Valuation Metrics
AVNT leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 33.6x trailing earnings, BCPC trades at a 18% valuation discount to AVNT's 41.0x P/E. On an enterprise value basis, AVNT's 12.2x EV/EBITDA is more attractive than BCPC's 19.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.3B | $5.1B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $5.2B |
| Trailing P/EPrice ÷ TTM EPS | 41.01x | 33.58x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.95x | 30.87x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.62x |
| EV / EBITDAEnterprise value multiple | 12.22x | 19.83x |
| Price / SalesMarket cap ÷ Revenue | 1.03x | 4.92x |
| Price / BookPrice ÷ Book value/share | 1.40x | 4.14x |
| Price / FCFMarket cap ÷ FCF | 17.16x | 29.51x |
Profitability & Efficiency
BCPC leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $7 for AVNT. BCPC carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to AVNT's 0.81x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs AVNT's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.6% | +12.4% |
| ROA (TTM)Return on assets | +2.6% | +9.4% |
| ROICReturn on invested capital | +3.9% | +12.2% |
| ROCEReturn on capital employed | +4.0% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 9 |
| Debt / EquityFinancial leverage | 0.81x | 0.15x |
| Net DebtTotal debt minus cash | $1.4B | $117M |
| Cash & Equiv.Liquid assets | $511M | $75M |
| Total DebtShort + long-term debt | $1.9B | $192M |
| Interest CoverageEBIT ÷ Interest expense | 3.61x | 15.23x |
Total Returns (Dividends Reinvested)
BCPC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BCPC five years ago would be worth $12,424 today (with dividends reinvested), compared to $7,726 for AVNT. Over the past 12 months, AVNT leads with a +4.1% total return vs BCPC's -2.2%. The 3-year compound annual growth rate (CAGR) favors BCPC at 8.2% vs AVNT's 0.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +16.0% | +3.6% |
| 1-Year ReturnPast 12 months | +4.1% | -2.2% |
| 3-Year ReturnCumulative with dividends | +2.3% | +26.6% |
| 5-Year ReturnCumulative with dividends | -22.7% | +24.2% |
| 10-Year ReturnCumulative with dividends | +27.8% | +160.5% |
| CAGR (3Y)Annualised 3-year return | +0.8% | +8.2% |
Risk & Volatility
BCPC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than AVNT's 1.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BCPC currently trades 86.7% from its 52-week high vs AVNT's 81.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 0.33x |
| 52-Week HighHighest price in past year | $44.85 | $183.90 |
| 52-Week LowLowest price in past year | $27.48 | $139.17 |
| % of 52W HighCurrent price vs 52-week peak | +81.4% | +86.7% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 32.9 |
| Avg Volume (50D)Average daily shares traded | 620K | 190K |
Analyst Outlook
AVNT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates AVNT as "Buy" and BCPC as "Buy". Consensus price targets imply 32.6% upside for AVNT (target: $48) vs 1.6% for BCPC (target: $162). For income investors, AVNT offers the higher dividend yield at 2.95% vs BCPC's 0.54%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $48.40 | $162.00 |
| # AnalystsCovering analysts | 20 | 10 |
| Dividend YieldAnnual dividend ÷ price | +2.9% | +0.5% |
| Dividend StreakConsecutive years of raises | 14 | 11 |
| Dividend / ShareAnnual DPS | $1.08 | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +2.1% |
BCPC leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AVNT leads in 2 (Valuation Metrics, Analyst Outlook).
AVNT vs BCPC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AVNT or BCPC a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus 0. 6% for Avient Corporation (AVNT). Balchem Corporation (BCPC) offers the better valuation at 33. 6x trailing P/E (30. 9x forward), making it the more compelling value choice. Analysts rate Avient Corporation (AVNT) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AVNT or BCPC?
On trailing P/E, Balchem Corporation (BCPC) is the cheapest at 33.
6x versus Avient Corporation at 41. 0x. On forward P/E, Avient Corporation is actually cheaper at 12. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AVNT or BCPC?
Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.
2%, compared to -22. 7% for Avient Corporation (AVNT). Over 10 years, the gap is even starker: BCPC returned +160. 5% versus AVNT's +27. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AVNT or BCPC?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
33β versus Avient Corporation's 1. 19β — meaning AVNT is approximately 262% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 81% for Avient Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — AVNT or BCPC?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus 0. 6% for Avient Corporation (AVNT). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to -51. 6% for Avient Corporation. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AVNT or BCPC?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus 2. 5% for Avient Corporation — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 6. 2% for AVNT. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AVNT or BCPC more undervalued right now?
On forward earnings alone, Avient Corporation (AVNT) trades at 12.
0x forward P/E versus 30. 9x for Balchem Corporation — 18. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 32. 6% to $48. 40.
08Which pays a better dividend — AVNT or BCPC?
All stocks in this comparison pay dividends.
Avient Corporation (AVNT) offers the highest yield at 2. 9%, versus 0. 5% for Balchem Corporation (BCPC).
09Is AVNT or BCPC better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33), 0. 5% yield, +160. 5% 10Y return). Both have compounded well over 10 years (BCPC: +160. 5%, AVNT: +27. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AVNT and BCPC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.